5933
Mounjaro curbs appetite, boosts fullness and energy, supporting effective weight loss when paired with a healthy diet and regular exercise.

Mounjaro, the brand name for tirzepatide, a prescription medication primarily used to enhance blood sugar control in adults with type 2 diabetes. It’s also gaining popularity and being extensively studied for its potential weight loss benefits. Achieving a healthy weight reduces the risk of serious health conditions, improves quality of life, and enhances mental and emotional well-being.

| Medication | Prices |
| Mounjaro 2.5mg | 14,900 THB |
| Mounjaro 5mg | 16,900 THB |
| Mounjaro 7.5mg | 22,900 THB |
| Mounjaro 10mg | 25,900 THB |
You will need to consult a doctor if you are interested in taking Mounjaro
Contact us at info.bkk@pulse-clinic.com or chat on your preferred platform:
To start your weight loss journey with PULSE Clinic, book an appointment online. Our doctor will review your details to ensure our weight management service suits your needs and safety. Once approved, we can give you Mounjaro pens that fit your needs deliver right to your doorstep throughout the treatment. You’ll then have a detailed consultation with a doctor on how to use the medication safely. After that, you might have check-in appointments to track your progress and address any issues.
Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist that mimics two body hormones, GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1). These hormones regulate blood sugar and appetite. They increase insulin release when blood sugar is high, reduce appetite, and slow stomach emptying. They also help lower blood sugar and promote weight loss.

Mounjaro is approved for Type 2 diabetes but is also used off-label for weight loss and obesity treatment, especially under the brand name Zepbound.
It’s a once-weekly subcutaneous injection given in the thigh, stomach, or upper arm.
Mounjaro is often compared to Ozempic and Wegovy, both of which contain semaglutide, a GLP-1 agonist. However, Mounjaro’s dual action may make it more effective for weight loss and blood sugar control in many patients.
Mounjaro suppresses appetite by promoting fullness after smaller portions, reducing food cravings and overeating. This helps maintain a calorie deficit, crucial for weight loss. Additionally, Mounjaro increases energy levels, aiding in physical activity and exercise, vital components of a successful weight loss strategy.
While effective for helping you feel less hungry, Mounjaro should be used with a healthy diet and regular exercise for optimal results.
The standard Mounjaro dosage schedule progresses in increments of 2.5mg every 4 weeks until you reach the optimal maintenance dose.

Mounjaro requires an adjusting period called titration. It is a gradual process of increasing your weekly dosage over several months. This allows your body to adapt to the medication and reduces the likelihood of gastrointestinal side effects such as nausea.
Usual maintenance doses for Mounjaro are 5 mg, 10 mg, and 15 mg.
The maintenance dose is the lowest effective amount that helps sustain target weight while minimizing side effects. You may not need to keep increasing to 15mg pens if 10mg is already working well with your body.
A doctor will determine the appropriate level. Considering factors for maintenance dose includes weight stability, appetite control, side effects, how well you adjust to the weekly injection, etc.
On the first use of each Mounjaro pen, you must prime the pen to the desired dose. Before using, turn the dial to select your dose. This process allows you to adjust the dosage at home according to your doctor’s instructions

| Desired dose | 2.5mg pens | 5mg pens | 7.5mg pens | 10mg pens | 12.5mg pens | 15mg pens |
| 2.5mg | 60 | 30 | 20 | 15 | 12 | 10 |
| 5mg | 60 | 40 | 30 | 24 | 20 | |
| 7.5mg | 60 | 45 | 36 | 30 | ||
| 10mg | 60 | 48 | 40 | |||
| 12.5mg | 60 | 50 | ||||
| 15mg | 60 |
Mounjaro and Ozempic are both effective for diabetes and weight loss, but Mounjaro may offer greater benefits for both.

Mounjaro, which works on two hormones (GIP and GLP-1), may lead to more significant weight loss and improved glucose control. Ozempic, on the other hand, targets only one hormone (GLP-1) and, while still highly effective, typically results in slightly less weight loss. Both medications necessitate weekly injections and can cause similar gastrointestinal side effects.
| Feature | Mounjaro | Ozempic |
|---|---|---|
| Generic name | Tirzepatide | Semaglutide |
| Drug class | Dual GIP & GLP-1 receptor agonist | GLP-1 receptor agonist |
| Approved for | Type 2 diabetes (branded as Mounjaro); weight loss (as Zepbound) | Type 2 diabetes (Ozempic); weight loss (as Wegovy) |
| Mechanism | Activates both GIP and GLP-1 receptors: enhances insulin secretion, suppresses appetite, slows digestion | Activates GLP-1 receptor: increases insulin, reduces appetite, slows digestion |
| Administration | Once-weekly injection | Once-weekly injection |
| Typical starting dose | 2.5 mg weekly, increased gradually | 0.25 mg weekly, increased gradually |
| Weight loss (average) | 15–22% of body weight (in clinical trials, higher doses) | 10–15% of body weight (in clinical trials) |
| Blood sugar reduction | Strong (greater A1C reduction than Ozempic in head-to-head trials) | Strong, but slightly less than Mounjaro |
| Common side effects | Nausea, vomiting, diarrhea, constipation, fatigue | Nausea, vomiting, diarrhea, constipation |
Trusted by over 100,000 patients from more than 196 countries and regions, PULSE CLINIC provides discreet, professional healthcare with privacy and respect at every step. Here to Help. Not to Judge!
A study reported by UK shows that the weight-loss injection Mounjaro (tirzepatide) leads to greater weight loss than Wegovy (semaglutide). Individuals with obesity who took Mounjaro lost over 20% of their body weight, while those who took Wegovy lost nearly 14%.

The trial compared tirzepatide and semaglutide in obese individuals without type 2 diabetes.
We don’t yet know if tirzepatide can lower the risk of heart and circulatory diseases as much, or more than semaglutide. More research is needed to confirm this.
Mounjaro may cause mild, temporary side effects such as nausea, diarrhea, and a decrease in appetite. These effects should go away on their own. If the symptoms keep happening or you feel like you cannot tolerate it, let the doctor know immediately to discuss a dosage reduction or delaying your next dose. Do not change your dosage schedule on your own.

Severe reactions are rare, but they are possible. Monitoring how you are feeling while using Mounjaro is important. If you experience difficulty breathing, swelling of the face, lips, or throat, or sudden dizziness after the injection, seek urgent care immediately.
Though it might sound tempting, Mounjaro injection is a prescription medication that should always be used under the guidance of a qualified healthcare professional to ensure safe and effective treatment. Doctors will evaluate your health, discuss the benefits and potential side effects, and decide if Mounjaro suits your weight management goals.
Mounjaro is usually prescribed for
Mounjaro® injections are not available over-the-counter. To determine if these medications are right for managing your diabetes, you will need to consult with a doctor. Speak with one of our healthcare providers today to see if Mounjaro® (Trizepatide Injection) is the right option for you.
Mounjaro starts working within hours, with initial effects like feeling fuller after 12 hours. Glucose-lowering effects peak around 4-6 months, while weight loss continues longer, with the greatest amount lost in the first 8 months.
Mounjaro, a GIP and GLP-1 receptor agonist, lowers blood glucose by increasing insulin release, reducing liver glucose production, and improving insulin sensitivity. It also promotes weight loss by slowing digestion, regulating appetite, and balancing hunger hormones.
Mounjaro’s effects wear off after a week, but it remains in the system for up to 25 days. Discontinue use one week before any surgery.
Mounjaro is a long-term diabetes medication used to manage blood glucose and reduce complications. Stopping Mounjaro may cause glucose and A1C levels to return to pre-treatment levels.
Weight regain is likely after stopping Mounjaro. People usually regained 14% of their body weight within a year. Keeping up with your eating and exercise habits after stopping Mounjaro can help reduce the risk of regaining weight rapidly.
Mounjaro is generally safe for Type 2 diabetes treatment, but share your medical history with your care team. Common side effects include nausea, diarrhea, and vomiting, while rare but serious side effects include hypoglycemia, allergic reactions, and kidney damage.
Contact us at info.bkk@pulse-clinic.com or chat on your preferred platform:
Chat with PULSE CLINIC ONLINE Department